Assyro AI

Orange Book product · Brand (NDA)

LEVOTHYROXINE SODIUM

LEVOTHYROXINE SODIUM

Brand (NDA)NDA 214253RX HIKMA

At a glance

May 17, 2021

Approved

Brand (NDA)

Application

Not listed

TE code

1

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    May 17, 2021

    5 yr 2 mo ago

  2. Today

  3. Patent 11154498 expires

    Listed drug product patent expiration.

    Jul 20, 2036

    in 10 yr 3 mo

Pharmaceutical detail

Active ingredient

LEVOTHYROXINE SODIUM

Strength

100MCG/ML

Dosage form

SOLUTION

Route

INTRAVENOUS

TE code

Not listed

Application

NDA 214253

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
11154498Jul 20, 2036in 10 yr 3 mo
Product
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.